The Onco-Urology Company

MED DISCOVERY SA
Route de la Corniche 4
1066 Epalinges - Switzerland

Tél +41 21 651 90 76 - Email

Scientific Publications

Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology

Cloutier SM, Chagas JR, Mach JP, Gygi CM, Leisinger HJ, Deperthes D. (2002) Eur J Biochem, 269:2747-54.

Phage display substrate: a blind method for determining protease specificity

Deperthes D. (2002) Biol Chem, 383:1107-12

Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates

Cloutier SM, Kundig C, Felber LM, Fattah OM, Chagas JR, Gygi CM, Jichlinski P, Leisinger HJ, Deperthes D. (2004) Eur J Biochem, 271:607-13

Evaluation of the CFP-substrate-YFP system for protease studies: advantages and limitations

Felber LM, Cloutier SM, Kundig C, Kishi T, Brossard V, Jichlinski P, Leisinger HJ, Deperthes D. (2004) Biotechniques, 36:878-85

Profiling of proteolytic activities secreted by cancer cells using phage display substrate technology

Cloutier SM, Kundig C, Gygi CM, Jichlinski P, Leisinger HJ, Deperthes D. (2004)
Tumour Biol, 25:24-30

Enzymatic profiling of human kallikrein 14 using phage-display substrate technology.

Felber LM, Borgoño CA, Cloutier SM, Kündig C, Kishi T, Chagas JR, Jichlinski P, Gygi CM, Leisinger HJ, Diamandis EP, Deperthes D (2005) Biol Chem, 386:291-8

Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14

Felber LM, Kündig C, Borgoño CA, Chagas JR, Tasinato A, Jichlinski P, Gygi CM, Leisinger HJ, Diamandis EP, Deperthes D, Cloutier SM (2006) FEBS J (in press)

Ok